United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United Kingdom News Beep | NewsBeep.com
United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Novo Nordisk

82 posts
MMedication
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q4 Results?
Read More

Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?

  • June 8, 2026
Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
HHealthcare
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
Read More

Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success

  • June 6, 2026
The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
MMedication
Why Canadians can now get cheaper generic Ozempic
Read More

Why Canadians can now get cheaper generic Ozempic

  • June 5, 2026
Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help reverse her…
MMedication
Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered
Read More

Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered

  • June 2, 2026
Eli Lilly’s Foundayo weight loss oral pill competes against Novo Nordisk’s oral Wegovy. (Photo by: Michael Siluk/UCG/Universal Images…
MMedication
Brazil approves first generic semaglutide pen after Ozempic patent expiry
Read More

Brazil approves first generic semaglutide pen after Ozempic patent expiry

  • May 26, 2026
SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it ‌had approved EMS’s Ozivy,…
MMedication
How GLP-1s are more than just weight-loss wonders – but not without risk
Read More

How GLP-1s are more than just weight-loss wonders – but not without risk

  • May 23, 2026
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
MMedication
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Read More

LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case

  • May 22, 2026
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
MMedication
Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
Read More

Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say

  • May 21, 2026
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
MMedication
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?
Read More

Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?

  • May 17, 2026
After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
HHealthcare
Best Healthcare Stocks to Buy in 2026
Read More

Best Healthcare Stocks to Buy in 2026

  • May 15, 2026
Biogen (NASDAQ: BIIB) and Novo Nordisk (NYSE: NVO) represent different opportunities within the healthcare sector: One is a…
MMedication
Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders
Read More

Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders

  • May 13, 2026
Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…
MMedication
Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric Push
Read More

Oral Ozempic US Launch And Partnerships Test Novo Nordisk Valuation

  • May 8, 2026
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
United Kingdom News Beep | NewsBeep.com
www.newsbeep.com